Genitourinary cancers. (2018)

• Record Type: Book
• Further Information: Note: Siamak Daneshmand, Kevin G. Chan, editors.
• Editors: Daneshmand, Siamak; Chan, Kevin G
• Contents: Intro; Contents; 1 New Imaging Techniques in Prostate Cancer; Abstract; 1 Introduction; 2 Multiparametric Magnetic Resonance Imaging; 3 Hyperpolarized Magnetic Resonance Imaging; 4 Choline Positron Emission Tomography; 5 Prostate-Specific Membrane Antigen; 6 Conclusions; References; 2 Targeted Ablative Therapies for Prostate Cancer; Abstract; 1 Introduction; 2 Cryotherapy; 2.1 History; 2.2 Technical Aspects; 2.3 Data; 2.4 Summary; 3 High-Intensity Focused Ultrasound (HIFU); 3.1 History; 3.2 Technical Aspects; 3.3 Data; 3.4 Summary; 4 Focal Laser Ablation (FLA); 4.1 History 4.2 Technical Aspects4.3 Data; 4.4 Summary; 5 Radiofrequency Ablation (RFA); 5.1 History; 5.2 Technical Aspects; 5.3 Data; 5.4 Summary; 6 Photodynamic Therapy (PDT); 6.1 History; 6.2 Technical Aspects; 6.3 Data; 6.4 Summary; 7 Irreversible Electroporation (IRE); 7.1 History; 7.2 Technical Aspects; 7.3 Data; 7.4 Summary; 8 Gold Nanoparticle-Directed Ablation (GNP); 8.1 History; 8.2 Technical Aspects; 8.3 Data; 8.4 Summary; 9 Conclusions; References; 3 Prostate Cancer Markers; Abstract; 1 Introduction; 1.1 Biomarkers; 1.2 Diagnostic, Prognostic, and Predictive Biomarkers 1.3 Regulation and Oversight1.4 Assessing Clinical Utility; 1.5 Clinical Situations; 2 Detection of Prostate Cancer; 2.1 Serum Markers; 2.2 Urinary Markers; 2.3 Negative Biopsy Tissue; 3 Summary Points-Detection of Prostate Cancer; 4 Initial Treatment Decision; 4.1 Summary Points-Initial Treatment Decision; 5 Post-radical Prostatectomy Prognosis and Adjuvant Treatment Decisions; 5.1 Summary Points-Post-radical Prostatectomy; 6 Conclusions and Future Directions; References; 4 Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and Beyond; 1 Introduction; 2 Circulating Tumor Cells 2.1 Identification and Enrichment2.2 Clinical Applications of CTCs in Prostate Cancer; 2.2.1 Enumeration: CTC Numbers as a Biomarker of Disease Activity; 2.2.2 Liquid Biopsy in Practice: Identifying Phenotypes Through CTC Characterization; 3 Plasma Cell-Free Genomic Materials; 3.1 Identification; 3.2 Clinical Applications of cfDNA in Prostate Cancer; 4 Extracellular Vesicles (EVs); 4.1 Overview and Preclinical Studies in Prostate Cancer; 4.2 Clinical Applications of Extracellular Vesicles in Prostate Cancer; 5 Summary; References; 5 Management of Small Renal Masses; Abstract; 1 Introduction 2 Diagnosis of Renal Tumors2.1 Recent Advances in Imaging Evaluation; 2.2 Renal Mass Biopsy; 3 Active Surveillance; 3.1 Tumor Characteristics and Growth Kinetics; 3.2 Patient Selection and Surveillance Follow-Up; 3.3 Outcomes; 3.4 Summary; 4 Surgical Excision; 4.1 Utilization Trends; 4.2 Preservation of Renal Function; 4.3 Surgical Approach; 5 Ablation; 6 Future Considerations; 7 Conclusion; References; 6 Advances in the Treatment of Metastatic Renal Cell Carcinoma; Abstract; 1 Introduction; 2 CheckMate 214; 3 CABOSUN; 4 Other First-Line Studies; 5 Future Management Paradigms for mRCC
• Publisher Details: Cham : Springer
• Publication Date: 2018
• Extent: 1 online resource
• Subjects: 616.9946; Medicine; Genitourinary organs -- Cancer; Oncology ; Urology; HEALTH & FITNESS / Diseases / General; MEDICAL / Clinical Medicine; MEDICAL / Diseases; MEDICAL / Evidence-Based Medicine; MEDICAL / Internal Medicine; Medical -- Urology; Urology & urogenital medicine; Medical -- Oncology; Oncology; Electronic books
• Languages: English
• ISBNs: 9783319933399; 3319933396
• Related ISBNs: 9783319933382; 3319933388
• Notes: Note: Online resource; title from PDF title page (EBSCO, viewed September 6, 2018)
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.